[Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
The specific pharmacotherapy in pregnant women is of great importance in chronic inflammatory rheumatic diseases. Before every potential pregnancy or afterwards the knowledge of pregnancy of women with inflammatory rheumatic disease, it is necessary to evaluate the pregnancy risk for patient and child. The purpose of this review is to give concise informations about the most frequent used drugs in rheumatology and their use in pregnancy and lactation.
Anić
Branimir
B
Zavod za klinicku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinicki bolnicki centar Zagreb, Kispatićeva 12, 10000 Zagreb.
Cikes
Nada
N
D016736:Antiphospholipid Syndrome / Q000188:drug therapy; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D005333:Fetus / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology; D007774:Lactation; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents